Marc Scheineson is quoted on a U.S. Food and Drug Administration decision allowing new language in abbreviated new drug applications.
In the News
November 29, 2017
The Pink Sheet | Indication “Carve In” Allowed Under Generic Labeling “Carve-Out” Authority, US FDA Says
Media Contact